冠心病和外周血管疾病患者的抗凝和抗血小板治疗

Anticoagulant and antiplatelet therapy for coronary heart disease and peripheral artery disease patients

摘要: 近年来，冠心病（CHD）和外周血管疾病（PAD）成为威胁人类健康的主要疾病。对CHD和PAD的药物治疗主要在于预防新的动脉粥样硬化的形成及稳定已存在的病变，最常用的药物治疗方法是抗血小板和抗凝治疗。本文通过对比大量临床试验来比较抗血小板和抗凝药物治疗CHD和PAD患者的效果以及安全性，总结了更有效和更安全的方案来预防动脉粥样硬化事件的发生。

Abstract: Coronary heart disease (CHD) and peripheral artery disease (PAD) have recently become major diseases threatening human health. The drug therapy for CHD and PAD is mainly to prevent the formation of new atherosclerosis and stabilize the existing lesions and the most commonly used drug therapy is antiplatelet and anticoagulant therapy. This paper compares a large number of clinical trials for patients with coronary heart disease and peripheral artery disease.